This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.
Through the CDF, NICE can appraise drugs while providing interim funding for up to two years to give patients access to drugs that have either a draft recommendation for routine use ... As we develop a new regulatory and access environment for medicines,
The new initiative aims to help countries to access affordable medicines to treat the major symptoms of COVID-19, including inflammation and respiratory problems linked to the disease. ... Access to medicine can be a challenge for patients in low- and
The grant will allow for the continuation of the CIRS and Gates Foundation’s collaborative efforts on the Optimising Efficiencies in Regulatory Agencies (OpERA) programme to expedite patient access to medicines ... The ultimate aim of the programme is
ENVI addressed two broad points related to public health. Firstly, the committee called for “targeted actions to ensure continued and rapid access to safe medicines and medical devices for patients, including ... The committee’s prioritisation of
Last November, GlobalData identified personalised medicine as a key improvement in the treatment pathway, but said that gaining access to these drugs still poses an issue. ... Despite rejecting Vitrakvi, NICE said that it was in discussions with Roche
Novartis gained inclisiran from its $9.7bn acquisition of the drug's developer The Medicines Company, which completed last week. ... UK's Medicines and Healthcare products Regulatory Agency's (MHRA) Early Access to Medicines Scheme (EAMS).
More from news
Approximately 4 fully matching, plus 440 partially matching documents found.
Access to healthcare, including affordable medicines, remains a top concern across the US. ... As more biosimilars enter the US market, patients treated with biologic medicines will have access to a broader set of more affordable treatment options.
patients by enhancing the critical medicines they depend on, broadening patient access and improving health outcomes around the world. ... 180+ molecules to specialised patient populations around the world, while simultaneously focusing on
NHS England will now pay pharma companies a guaranteed amount for access to new drugs to treat resistant infections for up to ten years, a reward potentially totalling £100m. ... Both the UK and US models treat access to novel antibiotic medicines like
This falls to 30 days for products included in the Early Access to Medicines Scheme (EAMS) or those designated for Fast Track Appraisal. ... Medicines that have open access – ie, there’s no restriction on their use – tend to perform better than
disease. Is there a way to accelerate patient access to medicines for earlystage cancers in the interim? ... Jason Ward is Head of Haematology and Group Director, Strategy, Policy &Operations, Oncology Market Access and Pricing at AstraZeneca.
More from intelligence
Approximately 0 fully matching, plus 97 partially matching documents found.
Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also
May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate
Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access
As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.
Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he
More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.
All while we were relocating our offices to our homes. But as we all know, the world of healthcare doesn’t ever stop – patients still need access to medicines and support ... HCPs had to adjust how they delivered care (often though telemedicine) and
When working to ensure access to affordable medicines to patients, will the EU institutions focus on prices – a message that seems to be coming through from the Commission? ... Hanover’s IPMA team is a leading international policy and market access
Claire Eldridge, CEO, comments: “It has been a privilege to work with our clients to help realise the potential of their interventions, to ensure patient access to innovation and to promote ... Worked to speed up access to innovative medicines and
The current NICE Methods Review is an opportunity that should be grasped by Government to enhance patient access to new medicines and simultaneously boost the attractiveness of the UK to the ... A triple win is on offer. Patients gain faster and fuller
This eventually could lead to delays in access to medicines for patients, especially for novel therapies. ... more than 15 people can access [a virtual preceptorship] all at the same time, and this could have a massive impact in the diagnosis of rare
More from PMHub
Approximately 0 fully matching, plus 23 partially matching documents found.
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...